Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs)

Published:2013-08 Issue:2 Volume:81 Page:252-258
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Pircher Andreas,Fiegl Michael,Untergasser Gerold,Heidegger Isabel,Medinger Michael,Kern Johann,Hilbe Wolfgang

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. Angiogenesis in cancer and other diseases;Carmeliet;Nature,2000

2. Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer;Salgia;Cancer,2011

3. Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer;Ulahannan;Cancer Invest,2011

4. Genes expressed in human tumor endothelium;St Croix;Science,2000

5. Endothelial cell-specific molecule 2 (ECSM2) localizes to cell-cell junctions and modulates bFGF-directed cell migration via the ERK-FAK pathway;Shi;PLoS ONE,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large-Scale Two-Sample Comparison of Support Sets;Journal of the American Statistical Association;2023-06-22

2. Bioinformatics analysis reveals biomarkers with cancer stem cell characteristics in kidney renal clear cell carcinoma;Translational Andrology and Urology;2021-08

3. Structural insights and evaluation of the potential impact of missense variants on the interactions of SLIT2 with ROBO1/4 in cancer progression;Scientific Reports;2020-12

4. DS-7080a, a Selective Anti-ROBO4 Antibody, Shows Anti-Angiogenic Efficacy with Distinctly Different Profiles from Anti-VEGF Agents;Translational Vision Science & Technology;2020-08-05

5. An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours;The Journal of Pathology: Clinical Research;2020-07-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3